HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 55.70
-0.30 (-0.54%)
At close: Dec 8, 2025
HeXun Biosciences Market Cap
HeXun Biosciences has a market cap or net worth of 2.58 billion as of December 8, 2025. Its market cap has decreased by -19.89% in one year.
Market Cap
2.58B
Enterprise Value
2.18B
Revenue
304.45M
Ranking
n/a
PE Ratio
19.65
Stock Price
55.70
Market Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 2.58B, a decrease of -38.05%. That is a compound annual growth rate of -19.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.58B | -17.04% |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
| Sep 7, 2023 | 4.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 259.78B |
| PharmaEssentia | 189.73B |
| Heron Neutron Medical | 95.61B |
| Lotus Pharmaceutical | 78.24B |
| Bora Pharmaceuticals Co., LTD. | 65.19B |
| Lin BioScience | 34.45B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 32.34B |